跳至主要内容
临床试验/NL-OMON43355
NL-OMON43355已完成不适用

Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 lesions: Can patient selection for biopsy be improved? - A confirmatory Multi-Center-Study - VTIQ

Jeroen Bosch Ziekenhuis0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • •Age >=18 years
  • •Patients with a lesion >= 0.5 cm, initially scored BI-RADS® 3, 4a, 4b or 4c in B-mode ultrasound
  • •Signed informed consent of study participation

排除标准

  • •Pregnant or lactating women
  • •Women with breast implants on the same side as the lesion
  • •Women that underwent local radiation or chemotherapy within the last 12 months
  • •Women with history of breast cancer or breast surgery in the same quadrant
  • •Lesions in or close to scar tissue (< 1cm)
  • •Skin lesions or lesions that have been biopsied previously
  • •Lesion larger than 4 cm
  • •No lesion should be included when more than 50% of the lesion is further down than 4 cm beneath the skin level

研究者

发起方
Jeroen Bosch Ziekenhuis

相似试验